Epidemiology
Introduction
The presence of more than one malignant colorectal lesion is classifi ed according to its onset period as synchronous or metachronous lesions. Synchronous cancer is defi ned as two or more neoplasms identifi ed simultaneously in the same patient or a second tumor identifi ed up to six months after the initial diagnosis. In turn, metachronous tumor is defi ned as a second primary lesion identifi ed six months after the detection of the fi rst cancer and located no more than 3 cm from the anastomosis.
Temporally, metachronous tumors are classifi ed as early if occurring within the fi rst three years after the primary lesion, while those occurring after three years are considered late. [1] [2] [3] It is speculated that synchronous colon carcinomas arise from a combination of environmental and genetic factors, as well as associated predisposing diseases. Among them is ulcerative colitis, a disease that, together with familial adenomatous polyposis (FAP), corresponds to 10% of synchronic tumors 3 . In addition to FAP, another syndrome associated with multiple colorectal adenocarcinoma is Hereditary Nonpolyposis Colorectal Carcinoma (HNPCC), also known as Lynch syndrome, which corresponds to 1 to 3% of all colorectal neoplasms. 1, 3 Estimates of the incidence of synchronous colorectal carcinomas vary, according to the literature, from 2 to 9%. [2] [3] [4] [5] [6] [7] [8] However, studies of greater internal validity, due to improved scientifi c design, state that the true prevalence is about 4% 2, 3, 6 . The incidence of synchronous neoplasia is slightly lower if patients with HNPCC are excluded, decreasing the values from 4 to 2.5%. 9 In turn, few studies have evaluated the incidence of metachronous cancer, which is around 1%. 2 This study aims to determine the prevalence of synchronous and metachronous colorectal tumor in a reference Service of Proctology in the state of Rio Grande do Sul, Brazil.
Method
The present is a cross-sectional study carried out between January and July 2012, involving all patients treated at the Proctology Service of Hospital Geral de Caxias do Sul in the period between January 2010 and March 2012.
Inclusion criteria consisted of patients who underwent surgical resection, preoperative histopathological diagnosis, and postoperative anatomopathological tumor analysis and adequately prepared colonoscopy before surgery.
Variables such as age, gender, comorbidities, tumor location, presence of synchronous or metachronous tumor, presence of hereditary syndrome and histological subtype were assessed using a data collection instrument obtained by patients' charts review.
Assessed comorbidities were systemic arterial hypertension (SAH), diabetes mellitus (DM), obesity classifi ed according to body mass index (BMI), dyslipidemia, smoking, alcoholism, lung disease, liver disease, kidney disease, thyroid disease and depression. Tumor location was defi ned as cecum and ileocecal valve, right colon, hepatic fl exure, transverse colon, splenic fl exure, left colon, sigmoid colon and high and low rectum. The presence of hereditary syndrome was evaluated and the syndromes included were FAP and HNPCC. Histologically, the tumors were classifi ed as adenocarcinoma, epidermoid tumor, undifferentiated and polypoid lipoma.
Data were stored in Microsoft Excel 2007 spreadsheets and statistical analyses were performed using SPSS software, release 17.0 ® .
Results
From January to July 2012, medical records of all patients with colorectal cancer treated at the Proctology Service from January 2010 to March 2012 were retrospectively reviewed. A total of 150 records were analyzed, of which 53.3% were males with a mean age of 63 (± 13.01) years old. Among the comorbidities assessed, the most prevalent was hypertension, seen in 24.6% of patients, followed by diabetes mellitus, lung and heart disease (Table 1) .
Regarding tumor location, the most affected portion was the sigmoid colon and high rectum (50.67%) followed by the low rectum (36%). Adenocarcinoma was the most prevalent histological subtype, corresponding to 89.3% of cases, followed by epidermoid tumors (1.33%) and undifferentiated and polypoid lipomas, both with an incidence of 0.67% (Table 2) .
Hereditary syndromes were identifi ed in fi ve patients (3.33%), all with adenocarcinoma histology. Of these, four patients had FAP and 1 had HNPCC.
From 150 patients, only four (2.67%) had synchronous neoplasia. The incidence of metachronous tumor was 0,67% (one patient), whose tumor location was in the cecum (Table 3 ). The mean age of patients with synchronous tumors was 61.5 (± 13.02) years old, of which three were females. The adenocarcinoma histological subtype was seen in four patients and only one patient was diagnosed with a hereditary syndrome (FAP).
When analyzing tumor characteristics of the four patients with synchronous lesions, it was demonstrated that two patients were classifi ed as C according to Dukes' criteria; the tumors did not have a predominant topography and total colectomy was indicated in three patients, with proctocolectomy being indicated for the fourth case (Table 4) .
Discussion
Colon cancer is the third most common malignancy in Brazil 10 and the second most common cause of death from malignancy in the western world. The risk of developing a tumor throughout the lifetime in the general population is approximately 5%. United States data estimated that 141,210 new colorectal cancer cases were diagnosed in the US in 2011.
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Patients with sporadic colorectal cancer or cases associated with genetic syndromes are at risk of developing synchronous tumors at diagnosis, as well as metachronous lesions in the follow-up. 6 Due to the possibility of the existence of synchronous tumors, all patients with a diagnosis of this type of tumor should have their colon thoroughly analyzed preoperatively to investigate the presence of a second or third lesion, which can modify the extent of the surgical procedure. 12 Although colonoscopy is the test of choice in the preoperative investigation, it is not, even when associated with double-contrast barium enema, enough to detect all synchronous lesions, with a sensitivity of 66%. 13 Therefore, the palpation of the entire colon and rectum is recommended during surgery to detect synchronous tumors not identifi ed at the preoperative evaluation.
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The preoperative detection of synchronous tumors not only allows establishing the appropriate surgical strategy, but also facilitates the follow-up plan after surgery. It is believed that the presence of synchronous lesions require a modifi cation in surgical extension in 34.4% of patients, as they indicate lesions in surgically distinct colonic segments. 2, 6 Estimates of the incidence of synchronous colorectal adenocarcinoma vary, according to the literature, from 2 to 9%. [2] [3] [4] [5] [6] [7] [8] The results of the present study are consistent with the literature, as the incidence in this population was 2.8%. We believe that the incidence found was lower than that reported in other studies due to the smaller number of patients. However, if we evaluate that only 4.5% of our sample had a diagnosis of hereditary adenocarcinoma and only one of these cases had synchronous tumors, we observe that the results of the present study are very similar to those described by other authors. According to Fante et al., the incidence of synchronous neoplasia is slightly lower if patients with hereditary pathologies are excluded, decreasing from 4 to 2.5%. 9 Of the four cases of synchronous tumors, two affected the rectal segment, whereas the remaining lesions were distributed between the cecum and sigmoid colon. This fi nding corroborates previous descriptions that suggest a higher prevalence of synchronous adenocarcinoma in cancers arising in the colon, when compared to rectal tumors. 6 Risk factors for synchronous tumors include male sex, family history, advanced age and the presence of synchronous adenomas. In our sample, 75% were females. However, this fi nding has no statistical signifi cance due to the small number of patients evaluated.
Age is a controversial subject, as several studies have indicated that synchronous tumors occur in older patients, 13 while other studies have shown that the patients were younger. Moreover, there are studies that showed no signifi cant difference regarding age of patients with a solitary tumor in comparison to those with synchronous tumors. 2, 3 The divergence regarding the results is possibly due to the fact that synchronous tumors were not stratifi ed by location or genetic predisposition.
This fact is demonstrated by the study of Fukatsu et al., in which there was no difference in age between the groups with isolated and synchronous tumors; however, when these were analyzed for tumor location, it was shown that the presence of both lesions in the right colon occurs in older patients, whereas both lesions in the left colon occur in younger patients 4 . This fi nding supports the theory that tumors of the right colon and left colon have distinct molecular biology features and different risk factors, as right colon tumors are more prevalent in the elderly and in females, while tumors of the left colon are more prevalent in younger males.
Moreover, few studies have evaluated the incidence of metachronous tumors. According to Chen et al., the incidence is approximately 1% (2), similar to that found in this study, of which incidence was 0.67%.
Conclusion
The incidence of synchronous colorectal tumors in this population was 2.67%, which is consistent with values previously reported in the literature, especially when cases of hereditary tumors were excluded. Moreover, the incidence of metachronous tumor was 0.67%, which also corroborates the literature fi ndings, although few authors have addressed this issue in particular. 
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